Heart hypertrophy is a common finding of
acromegaly, a syndrome due to GH excess. Impairment of
adenine nucleotide translocase-1 (ANT-1) gene, the main mitochondrial
ADP/
ATP exchanger, leads to
cardiac hypertrophy. The aim of the study was to evaluate cardiac expression and the functional role of ANT-1 in 1- to 12-month-old transgenic mice overexpressing bovine GH (acromegalic mice, Acro) and littermate controls (wild-type mice, Wt). GH specificity of
protein degree variation was assessed treating Acro with
pegvisomant, a GH receptor competitor. Tissue levels of ANT-1,
NF-kappaB,
ATP, and
lactic acid were evaluated by western blot, bioluminescence, and Fourier transform infrared spectroscopy respectively. The degree of ANT-1 expression was higher in 1-month-old Acro than in Wt (47+/-5% OD vs 33+/-4% OD, P<0 01). On the contrary, ANT-1 expression was lower in 3- to 12-month-old Acro than in Wt (P<0 03). Changes in ANT-1 expression were associated with consistent changes of cellular
ATP content, increasing at 1 month (P<0 05) and reducing thereafter in Acro when compared with Wt (P<0 04). Treatment with
pegvisomant abolished ANT-1 and
ATP changes observed in 1- and 3-month-old Acro, thus supporting a GH-dependent mechanism. Reduced
ATP generation in hypertrophied hearts of older Acro was associated with increased
lactic acid levels suggesting that part of energy was due to glycolysis. Variations in ANT-1 expression were linked to GH through changes in
NF-kappaB, the levels of which changed accordingly. In conclusion, 1-month-old acromegalic mice had increased ANT-1 expression and higher degree of
ATP production. Long-standing disease was associated with a consistent reduction of ANT-1 and
ATP tissue levels, which became GH-independent in older animals. This study demonstrated a direct effect of GH on key
proteins involved in energy metabolism of acromegalic hearts.